1. Home
  2. Labeler Index
  3. Sumitomo Pharma Co., Ltd.
  4. 38217-0030
  5. NDC Package Code: 38217-0030-0 Droxidopa

NDC Package 38217-0030-0 Droxidopa

Powder - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
38217-0030-0
Package Description:
1 BAG in 1 DRUM / 1 POWDER in 1 BAG
Product Code:
38217-0030
Non-Proprietary Name:
Droxidopa
Substance Name:
Droxidopa
Usage Information:
Droxidopa is used to treat symptoms of low blood pressure when standing, caused by a certain medical condition (neurogenic orthostatic hypotension-NOH). This medication can lessen symptoms of low blood pressure when standing (orthostatic hypotension), such as dizziness, lightheadedness, or the "feeling that you are about to black out." Droxidopa is used by people whose daily activities are severely affected by this condition, even after other treatments are used (such as support stockings, water bolus). It is thought to work by making the blood vessels become more narrow, which increases blood pressure.
11-Digit NDC Billing Format:
38217003000
Product Type:
Drug For Further Processing
Labeler Name:
Sumitomo Pharma Co., Ltd.
Dosage Form:
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s):
  • DROXIDOPA 40 kg/1
    • Sample Package:
    N/A
    Marketing Category:
    DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
    Start Marketing Date:
    02-18-2014
    End Marketing Date:
    12-31-2030
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 38217-0030-0?

    The NDC Packaged Code 38217-0030-0 is assigned to an UNFINISHED drug package of 1 bag in 1 drum / 1 powder in 1 bag of Droxidopa, drug for further processing labeled by Sumitomo Pharma Co., Ltd.. The product's dosage form is powder and is administered via form.

    Is NDC 38217-0030 included in the NDC Directory?

    Yes, Droxidopa is an UNFINISHED PRODUCT with code 38217-0030 that is active and included in the NDC Directory. The product was first marketed by Sumitomo Pharma Co., Ltd. on February 18, 2014.

    What is the 11-digit format for NDC 38217-0030-0?

    The 11-digit format is 38217003000. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-138217-0030-05-4-238217-0030-00